IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Philadelphia Chromosome Negative

M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Dormant

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 95/ 100

Competitive context

0 Active assets in the Philadelphia Chromosome Negative cohort.

Asset / Sponsor	Phase	Rating
MERCAPTOPURINE ANHYDROUS M.D. Anderson Cancer Center	Phase 2	CCC
DEXAMETHASONE M.D. Anderson Cancer Center	Phase 2	CCC
Blinatumomab M.D. Anderson Cancer Center	Phase 2	CCC
FILGRASTIM M.D. Anderson Cancer Center	Phase 2	CCC
PEGFILGRASTIM M.D. Anderson Cancer Center	Phase 2	CCC

View all 10 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB